Primer On Multiple Sclerosis

This text provides a comprehensive overview of the clinical and basic science aspects of MS. It is designed to be of practical use to clinical neurologists, and addresses all of the major issues that may occur in the management of persons with MS.

Recent rapid changes in the field of multiple sclerosis management have made the task of staying well-informed a challenge for neurologists, and even more so for other healthcare practitioners who are involved in symptom evaluation and treatment. Multiple Sclerosis for the Non-Neurologist is an up-to-date resource for physicians, residents, fellows, and others who care for patients with MS. It contains authoritative information on all aspects of this complex disease, including monitoring requirements for patients with MS, potential risks and adverse events of disease modifying or symptomatic therapies, and possible drug interactions and contraindications of medications.

A Primer of Neuroimmunological Disease is a significant new resource for anyone interested in conditions such as multiple sclerosis(MS), myasthenia gravis, and neurological infections. It is a practical and balanced guide to the diagnosis and treatment of neuroimmunological disease. A Primer of Neuroimmunological Disease distinguishes itself by providing a range of features not generally included in texts on neuroimmunology. These include broad presentation of information in the form of figures and tables; strong cohesion among topics by focusing on a few prototypic neuroimmunological diseases, which serve as a foundation from which to explore other neuroimmunological diseases; a single author perspective, with references across chapters; and a focus on the overlap between neuroimmunological and neuroinfectious diseases. Neurologists, immunologists, infectious disease specialists, neuroscientists and others interested in neuroimmunological diseases such as MS will find A Primer of Neuroimmunological to be a state-of-the-art resource.

This edition fills one of the few remaining 'neurologic gaps' within the 'Contemporary Neurology' series. The book offers proven, effective treatments for specific presentations and symptoms of multiple sclerosis along with a pathophysiological explanation of why they work.

Multiple Sclerosis: A Mechanistic View provides a unique view of the pathophysiology of multiple sclerosis (MS) and related disorders. As the only book on the market to focus on the mechanisms of MS rather than focusing on the clinical features and treatment of the disease, it describes the role of genetic and environmental factors in the pathogenesis of MS, the role of specific cells in the pathophysiology of the disease, and the pathophysiology of inflammatory and neurodegenerative disorders related to MS. The book provides discussion of neurodegeneration and neuroregeneration, two critical emerging areas of research, as well as detailed discussion of the mechanisms of action of the approved and investigational drugs for treatment of MS and the emerging role of magnetic resonance spectroscopy (MRI) in investigations into MS. It is the only book on the market to offer comprehensive coverage of the known mechanisms of MS and related diseases, and contains contributions from physicians and researchers who are worldwide experts in the field of study. Focuses on the pathophysiologic mechanisms of multiple sclerosis and the mechanisms of action in agents for the treatment of MS Discusses the roles of neurodegeneration and neuroregeneration in MS and related diseases Authored and edited by international leaders in the field of MS research

This book has been written for those newly diagnosed with multiple sclerosis. It is a guide to learning about the disease, its potential impact on your life, and the medical treatments now available for managing it successfully. This is a time of great excitement in research and advances in clinical management, such that most people who have multiple sclerosis can lead full and productive lives. This fourth edition is current and updated throughout, and includes a review of the controversy surrounding CCVSI and multiple sclerosis, discussion of the new pill Gelenya and other drugs in development for multiple sclerosis, new information on the drug Tysabri, and discussion of treatments and complementary and alternative medicine in MS. This the place to begin your education about MS.

Two-and-a-half million people world-wide and 400,000 Americans suffer from the chronic disease multiple sclerosis. Understanding Multiple Sclerosis presents both general information about MS and valuable, specific advice. Who gets MS? What are its symptoms? What are its effects on the bodies and minds of people afflicted? How does one plan for the future after a diagnosis? From basic biology to new advances in treatment, Understanding Multiple Sclerosis covers the topics most relevant to people with MS and to their families and friends. Chapters provide an introduction to genetic, demographic, and geographic factors; basic biology of MS, with descriptions of both the central nervous system and the immune system; characteristic symptoms of MS; diagnostic criteria and different types of MS treatments, over-the-counter medications, and alternative medicines; lifestyle adjustments and coping strategies, along with advice on long-term health insurance and financial planning; and current and ongoing MS research and advances.